As the world authoritative health institutions, WHO has assembled relevant functions and industry experts to conduct a comprehensive assessment to the public health potential transmission risk of the infectious diseases since December 2015, mainly focusing on severe emerging diseases with potential to generate a public health outbreak worldwide, and for which insufficient or no preventive and curative solutions exist. WHO Research and Development Blueprint on prioritized infectious diseases has been formulated using the scientific methodology for statistics and assessment, and based on experience of emergency response to the outbreak of infectious diseases. This program determines the standard and assessment method for the priority infectious diseases, issues the annual list of infectious diseases prioritized under the Research and Development Blueprint. The program aims to guide public health departments, relevant scientific research institutes and enterprises to deepen the exchange and cooperation, concentrate superior resources, quickly identify a nascent outbreak, obtain the most advanced products including pathogen’s diagnostic reagents, remedial drugs and control vaccine products, isolate infection source and arrange medical treatment. |